A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

NCT03847207 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HTL0030310
DRUG: Pasireotide
DRUG: Placebo

Sponsor

Nxera Pharma UK Limited